Bayer Ag
SpainAll drugs from this manufacturer
-
It is used to treat certain types of pulmonary hypertension in adults and in children aged 6 years and older, such as chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). It helps to widen the blood vessels in the lungs to reduce symptoms and improve physical activity.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 1 mg -
It is used to treat certain types of pulmonary hypertension, such as chronic thromboembolic pulmonary hypertension (CTEPH) in adults, and pulmonary arterial hypertension (PAH) in adults and children aged 6 years and older.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 1,5 mg -
It is used to treat certain types of pulmonary hypertension, specifically chronic thromboembolic pulmonary hypertension (CTEPH) in adults, and pulmonary arterial hypertension (PAH) in adults and children aged 6 years and older.
Dosage form: tablets, film-coated
Active substance Dosage riociguat 2 mg -
It is used to treat certain types of pulmonary hypertension in adults and in children aged 6 years and older, specifically chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH).
Dosage form: tablets, film-coated
Active substance Dosage riociguat 2,5 mg -
It is used for the treatment of multiple sclerosis, both in individuals presenting with first symptoms and at high risk of developing the disease, and in patients with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.
Dosage form: powder and solvent for solution for injection
Active substance Dosage interferon beta-1b 250 µg -
It is used to treat adults with cardiomyopathy (a disease of the heart muscle) caused by transthyretin amyloidosis (ATTR-CM).
Dosage form: tablets, film-coated
Active substance Dosage acoramide hydrochloride 400 mg -
It is used to treat ocular disorders in adults that affect the macula, such as age-related macular degeneration (exudative AMD), vision impairment due to diabetic macular edema, and vision impairment due to retinal vein occlusion.
Dosage form: solution for injection
Active substance Dosage aflibercept 114,3 mg/ml -
It is used to treat eye disorders in adults that affect the macula, such as age-related macular degeneration (wet AMD), diabetic macular edema, and macular edema caused by retinal vein occlusion.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage aflibercept 114,3 mg/ml -
What is Eylea used for?:
Dosage form: solution for injection
Active substance Dosage aflibercept 40 mg -
It is used to treat various eye diseases in adults, such as exudative age-related macular degeneration (AMD), macular edema caused by retinal vein occlusion (central retinal vein or branch retinal vein occlusion), diabetic macular edema, and myopic choroidal neovascularization.
Dosage form: solution for injection
Active substance Dosage aflibercept 40 mg -
It is used to treat and prevent bleeding in adults, adolescents, and children aged 7 years or older with hemophilia A (hereditary factor VIII deficiency) who have already received previous treatments.
Dosage form: powder and solution for injection
Active substance Dosage damoctocog alfa pegol 1000 UI -
It is used to treat and prevent bleeding episodes in adults, adolescents, and children aged 7 years and older with hemophilia A (inherited factor VIII deficiency) who have previously received factor VIII treatment.
Dosage form: powder and solution for injection
Active substance Dosage damoctocog alfa pegol 2000 UI -
It is used to treat and prevent bleeding in adults, adolescents, and children aged 7 years or older with hemophilia A (hereditary factor VIII deficiency) who have previously received treatment.
Dosage form: powder and solution for injection
Active substance Dosage damoctocog alfa pegol 3000 UI -
It is used to treat and prevent bleeding in adults, adolescents, and children aged 7 years or older with hemophilia A (hereditary factor VIII deficiency) who have previously received treatment.
Dosage form: powder and solution for injection
Active substance Dosage damoctocog alfa pegol 500 UI -
It is used to treat adults with chronic kidney disease associated with type 2 diabetes.
Dosage form: tablets, film-coated
Active substance Dosage finerenone 10 mg -
It is used to treat adults with chronic kidney disease associated with type 2 diabetes.
Dosage form: tablets, film-coated
Active substance Dosage finerenone 20 mg -
It is used to treat and prevent bleeding in adults, adolescents, and children of any age who suffer from hemophilia A (hereditary factor VIII deficiency).
Dosage form: powder and solvent for solution for injection
Active substance Dosage octocog alfa 1000 UI -
It is used to treat and prevent bleeding in adults, adolescents, and children of any age who suffer from hemophilia A (hereditary factor VIII deficiency).
Dosage form: powder and solvent for solution for injection
Active substance Dosage octocog alfa 2000 UI -
It is used to treat and prevent bleeding in adults, adolescents, and children of any age who suffer from hemophilia A (hereditary factor VIII deficiency).
Dosage form: powder and solvent for solution for injection
Active substance Dosage octocog alfa 250 UI -
It is used to treat and prevent bleeding in adults, adolescents, and children of any age who suffer from hemophilia A (hereditary factor VIII deficiency).
Dosage form: powder and solvent for solution for injection
Active substance Dosage octocog alfa 3000 UI -
It is used to treat and prevent bleeding in adults, adolescents, and children of any age who suffer from hemophilia A (hereditary factor VIII deficiency).
Dosage form: powder and solvent for solution for injection
Active substance Dosage octocog alfa 500 UI -
It is used to treat liver cancer, advanced-stage kidney cancer (when standard treatment is ineffective or unsuitable), and thyroid cancer.
Dosage form: tablets, film-coated
Active substance Dosage sorafenib tosylate 200 mg -
It is used to treat adult men with prostate cancer that has not spread to other parts of the body and no longer responds to testosterone-lowering treatments, or that has spread but does respond to such treatment.
Dosage form: tablets, film-coated
Active substance Dosage darolutamide 300 mg -
It is used to treat certain types of cancer in adults, such as metastatic colorectal cancer (colon or rectal cancer), gastrointestinal stromal tumors (GIST), and liver cancer, in cases where other treatments have been used previously.
Dosage form: tablets, film-coated
Active substance Dosage regorafenib 40 mg -
It is used to treat adults with long-term heart failure who have had a recent increase in their symptoms, such as shortness of breath, fatigue, or swelling due to fluid buildup.
Dosage form: tablets, film-coated
Active substance Dosage vericiguat 10 mg -
It is used to treat adults with long-term heart failure who have experienced a recent increase in symptoms, such as shortness of breath, fatigue, or swelling due to fluid buildup.
Dosage form: tablets, film-coated
Active substance Dosage vericiguat 2,5 mg -
It is used to treat adults with long-term heart failure who have experienced a recent increase in symptoms, such as shortness of breath, fatigue, or swelling due to fluid buildup.
Dosage form: tablets, film-coated
Active substance Dosage vericiguat 5 mg -
It is used in adults, adolescents, and children to treat solid tumors (cancer) caused by a change in the NTRK gene, provided they are advanced, have spread, or surgery would involve serious complications, and no other satisfactory treatment options exist.
Dosage form: capsules, hard
Active substance Dosage larotrectinib sulfate 122,9 mg -
It is used in adults, adolescents, and children to treat solid tumors (cancer) caused by a genetic change in the neurotrophic tyrosine kinase receptor (NTRK) gene, when the cancer is advanced, has spread, surgery is complicated, and no other satisfactory treatment options are available.
Dosage form: solution, oral
Active substance Dosage larotrectinib sulfate 24,6 mg/ml -
It is used in adults, adolescents, and children to treat solid tumors (cancer) caused by a change in the NTRK gene, provided they are advanced, have spread, or surgery would involve serious complications and no other satisfactory treatment options are available.
Dosage form: capsules, hard
Active substance Dosage larotrectinib sulfate 30,7 mg -
It is used in full-term newborns, infants, children, and adolescents under 18 years of age to treat blood clots and prevent them from reappearing in the veins or pulmonary blood vessels, following an initial treatment of at least 5 days with injectable medications.
Dosage form: suspension, oral for preparation from granules
Active substance Dosage rivaroxaban 51,7 mg -
It is used in adults to prevent the formation of blood clots in veins after hip or knee replacement surgery. It is also used to treat blood clots in the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg -
It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat blood clots in the leg veins (deep vein thrombosis) or in the lungs (pulmonary embolism), also helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg -
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg -
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from recurring.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg -
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you have non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots after initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg -
It is used to reduce the risk of suffering a new myocardial infarction or death from heart or blood vessel diseases in adults with acute coronary syndrome. It also helps to reduce the risk of clot formation in people with coronary or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2,5 mg -
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), as well as to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg -
It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg -
It is used to treat adults with castration-resistant advanced prostate cancer that has spread to the bone and causes symptoms, such as pain, after having received at least two other specific treatments.
Dosage form: solution for injection
Active substance Dosage radio 223 dichloride 1000 kilobequerelio